News Releases
Metacrine Broadens Management Team with Two Key Hires
SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today announced two new key management appointments. Trisha M.
Apr 17, 2018
Metacrine Raises $36 Million in Series A Financing
Appoints Neil McDonnell, CEO, Along with Executive Team and Board San Diego, CA – Metacrine, Inc., a biotechnology company focused on targeting metabolic disease through advances in endocrine research, today announced it has raised $36 million in a Series A financing.
Aug 5, 2015
Displaying 61 - 69 of 69